登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600561 证券简称：江西长运 公告编号：临2025-064 江西长运股份有限公司 关于子公司诉讼进展情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 是否会对上市公司损益产生负面影响：本诉讼案件后续执行结果尚存在不确定性，暂无法确定诉讼对 公司子公司深圳市华嵘财务信息咨询有限公司本期或期后利润的影响金额。 一、本次诉讼的基本情况 江西长运股份有限公司（以下简称"公司"或"本公司"）全资子公司深圳市华嵘财务信息咨询有限公司 （原名深圳市华嵘商业保理有限公司，以下简称"华嵘公司"）因相关方拖欠保理款，依法向深圳市福田 区人民法院提起民事诉讼，要求被告方媛立即向华嵘公司支付借款本金人民币1,000万元及利息，和律 师费11万元。 2020年10月22日，华嵘公司收到深圳市福田区人民法院出具的（2020）粤0304民初55722号《受理案件 通知书》。2021年10月29日，华嵘公司收到深圳市福田区人民法院出具的（2020）粤0304民初55 ...

一、本次诉讼的基本情况 江西长运股份有限公司（以下简称"公司"或"本公司"）全资子公司深圳 市华嵘财务信息咨询有限公司（原名深圳市华嵘商业保理有限公司，以下简称"华 嵘公司"）因相关方拖欠保理款，依法向深圳市福田区人民法院提起民事诉讼， 要求被告方媛立即向华嵘公司支付借款本金人民币 1,000 万元及利息，和律师费 11 万元。 2020 年 10 月 22 日，华嵘公司收到深圳市福田区人民法院出具的（2020） 粤 0304 民初 55722 号《受理案件通知书》。2021 年 10 月 29 日，华嵘公司收到 深圳市福田区人民法院出具的（2020）粤 0304 民初 55722 号《民事判决书》。于 都县福兴房地产建设开发有限公司（以下简称"于都福兴公司"）不服广东省深 圳市福田区人民法院（2020）粤 0304 民初 55722 号民事判决，向深圳市中级 人民法院提出上诉。2023 年 1 月 19 日，华嵘公司收到广东省深圳市中级人民法 院出具的（2022）粤 03 民终 3929 号《民事判决书》，广东省深圳市中级人民法 1 案件所处的诉讼阶段：案件执行 上市公司子公司所处的当事人地位：原告、申请执 ...

江西长运公告称，其全资子公司华嵘公司因相关方拖欠1000万元保理款及利息、11万元律师费提起诉 讼。2023年深圳中院终审维持原判，华嵘公司申请强制执行。2024年4月，因被执行人暂无财产可供执 行，法院终结本次执行程序。华嵘公司申请恢复执行后，案外人汤昌鹏、李兰秀对执行钟福源名下房产 提出异议。2025年11月28日，法院裁定驳回其异议请求。因执行结果不确定，暂无法判断对该子公司利 润的影响，华嵘公司已对涉案应收保理款全额计提1000万元坏账准备。 ...

Core Viewpoint - The company held a performance briefing for the third quarter of 2025, addressing investor inquiries and discussing future business strategies and financial performance [1][12]. Performance Briefing Details - The performance briefing took place on November 28, 2025, from 10:00 to 11:00 AM at the Shanghai Stock Exchange's online roadshow center [1]. - Key executives, including the chairman and financial director, participated in the briefing to engage with investors [1]. Investor Inquiries and Company Responses - **New Business Opportunities**: The company is exploring potential new business avenues beyond its current road passenger transport operations, aiming for a second growth curve while adhering to legal and regulatory requirements [2][7]. - **Third Quarter Performance Decline**: The net profit attributable to shareholders for Q3 2025 was -18.03 million yuan, primarily due to a decrease in asset disposal income by 16.46 million yuan compared to the same period last year [3][9]. - **Financing Plans**: The company plans to apply for a trust loan of up to 1 billion yuan from China Everbright International Trust Co., Ltd., with a term of five years, pending shareholder approval [4]. - **M&A Plans**: The company is open to mergers and acquisitions that align with its strategic goals, considering market conditions and potential synergies [5][6]. - **Cash Flow Improvement**: The company reported a cash flow from operating activities of 211 million yuan for the first three quarters of 2025, a 5.39% increase year-on-year, indicating improved operational cash generation [8]. - **Future Growth Strategies**: The company aims to enhance its digital capabilities and explore high-value services, such as cold chain logistics, to drive new growth [10]. - **ESG Commitment**: The company has emphasized its commitment to ESG principles and has been publishing a corporate social responsibility report for 17 consecutive years, integrating ESG into its daily operations [11].

一、业绩说明会召开情况 2025年11月28日上午10:00-11:00，公司董事长王晓先生、独立董事肖征山 先生、董事兼副总经理刘磊先生（代行总经理职责）、财务总监傅琳雁女士、董 事会秘书魏春云先生出席了本次业绩说明会，与投资者进行互动交流和沟通，就 投资者关注的问题在信息披露允许的范围内进行了回答。 二、投资者提问及公司回复情况 证券代码：600561 证券简称：江西长运 公告编号：临 2025-063 江西长运股份有限公司关于 2025 年第三季度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江西长运股份有限公司（以下简称"公司"）于2025年11月28日（星期五） 上 午 10:00-11:00 在 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/），以网络互动方式召开2025年第三季度业绩 说明会。关于本次业绩说明会召开事项，公司已于2025年11月21日在上海证券交 易所网站（www.sse.com.cn ...

Market Overview - The railway and highway sector experienced a decline of 0.28% on November 26, with Fujian Expressway leading the drop [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Stock Performance - Notable gainers in the railway and highway sector included Sichuan Chengyu, which rose by 1.35% to a closing price of 6.00, and Hainan Airlines, which increased by 1.30% to 10.11 [1] - Fujian Expressway saw the largest decline, dropping 3.02% to a closing price of 3.85 [2] Trading Volume and Value - The trading volume for Sichuan Chengyu was 121,600 shares, with a transaction value of approximately 72.87 million yuan [1] - Fujian Expressway had a trading volume of 1,772,400 shares, with a transaction value of about 6.95 million yuan [2] Capital Flow - The railway and highway sector saw a net outflow of 174 million yuan from institutional investors, while retail investors contributed a net inflow of 43 million yuan [2] - Major stocks like Hainan Expressway and Iron Dragon Logistics attracted significant net inflows from retail investors, indicating varied investor sentiment across the sector [3]

Core Viewpoint - Jiangxi Changyun announced the convening of its 32nd meeting of the 10th board of directors on November 24, 2025, via communication voting, discussing the proposal for the third extraordinary shareholders' meeting in 2025 [1] Group 1: Financial Performance - For the year 2024, Jiangxi Changyun's revenue composition is as follows: passenger transportation accounts for 47.56%, freight transportation for 25.31%, other businesses for 18.26%, and sales for 8.87% [1] - As of the report date, Jiangxi Changyun has a market capitalization of 1.9 billion yuan [1] Group 2: Related News - Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a paper profit of 24.92 million yuan for the actual controller and his brother [1]

Group 1: Financial Products and Investment Performance - The issue of inflated returns on bank wealth management products has gained significant attention, with many investors reporting discrepancies between advertised and actual returns [1] - Industry experts call for standardized performance displays and emphasize the need for investors to develop a more professional and rational understanding of performance benchmarks [1] - Liang Hong, a prominent private equity manager, publicly apologized for underperforming against major indices, attributing the decline to three main factors: heavy investments in innovative drugs, hardware companies, and stablecoin stocks [1][2] Group 2: Robotics and Electric Vehicles - The Ministry of Industry and Information Technology announced the establishment of a standardization committee for humanoid robots, with representatives from several listed companies included [2] - According to TrendForce, global sales of new energy vehicles reached 5.39 million units in Q3 2025, marking a 31% year-on-year increase, with battery electric vehicles (BEVs) growing by 48% [2] Group 3: Corporate Developments and Investments - Tuozhu denied reports of Tencent's investment in its latest funding round, stating that no current financing is taking place [3] - Jiangxi Changyun announced plans to publicly transfer land use rights and assets for 7.787 million yuan [5] - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund focused on the intelligent industry [6] - Jusaylong intends to increase its subsidiary's capital by 170 million yuan through a debt-to-equity swap [7] - ST Sansheng received 254 million yuan from restructuring investors [8] - Lege Co., Ltd. plans to repurchase shares worth 40 to 80 million yuan [9] - Petty Co., Ltd. announced a share buyback plan of 50 to 70 million yuan [11] Group 4: Market Performance - The market showed a rebound with all major indices closing in the green, driven by strong performances in the aerospace, military, and AI application sectors [15] - The total trading volume in the Shanghai and Shenzhen markets was 1.73 trillion yuan, reflecting a decrease from the previous trading day [15]

Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

Core Points - Jiangxi Changyun announced plans to apply for a trust loan of up to 1 billion yuan from China Everbright International Trust Co., Ltd. [2] - The loan will have a term of 5 years and is intended to support the company's financing needs [2] - The company's indirect controlling shareholder, Nanchang Transportation Investment Group Co., Ltd., will provide a joint liability guarantee for this financing [2] Summary by Category Company Actions - Jiangxi Changyun's board of directors approved the proposal to seek trust financing [2] - The company aims to secure a trust loan not exceeding 1 billion yuan [2] Financial Details - The proposed loan will have a duration of 5 years [2] - The financing will be backed by a guarantee from the company's indirect controlling shareholder [2] Stakeholder Involvement - Nanchang Transportation Investment Group Co., Ltd. is involved as the guarantor for the trust loan [2]